Home/Filings/4/0001835597-25-000013
4//SEC Filing

Donnelly Noel 4

Accession 0001835597-25-000013

CIK 0001835597other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 3:28 PM ET

Size

21.0 KB

Accession

0001835597-25-000013

Insider Transaction Report

Form 4
Period: 2025-11-04
Donnelly Noel
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-11-04203,3390 total
    Exercise: $10.88Exp: 2031-11-10Common Stock (203,339 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-11-04+203,339203,339 total
    Exercise: $4.53Exp: 2031-11-10Common Stock (203,339 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-11-04169,0370 total
    Exercise: $12.00Exp: 2032-05-05Common Stock (169,037 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-11-04+169,037169,037 total
    Exercise: $4.53Exp: 2032-05-05Common Stock (169,037 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-11-04144,0000 total
    Exercise: $15.25Exp: 2033-02-28Common Stock (144,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-11-04+144,000144,000 total
    Exercise: $4.53Exp: 2033-02-28Common Stock (144,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-11-04144,0000 total
    Exercise: $16.62Exp: 2034-02-28Common Stock (144,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-11-04+144,000144,000 total
    Exercise: $4.53Exp: 2034-02-28Common Stock (144,000 underlying)
Footnotes (3)
  • [F1]On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934.
  • [F2]This stock option vests over four years following the vesting commencement date (October 15, 2021) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date.
  • [F3]This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date.

Issuer

PepGen Inc.

CIK 0001835597

Entity typeother

Related Parties

1
  • filerCIK 0001922546

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 3:28 PM ET
Size
21.0 KB